Capricor Therapeutics Inc (CAPR)
13.03
-0.25
(-1.88%)
USD |
NASDAQ |
Apr 25, 16:00
13.04
0.00 (0.00%)
Pre-Market: 20:00
Capricor Therapeutics Shareholders Equity (Quarterly): 145.46M for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arcturus Therapeutics Holdings Inc | 240.98M |
| Envista Holdings Corp | 2.935B |
| Perspective Therapeutics Inc | 290.67M |
| Protalix BioTherapeutics Inc | 43.21M |
| Armata Pharmaceuticals Inc | -48.02M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 170.48M |
| Total Liabilities (Quarterly) | 25.02M |
| Current Ratio | 7.771 |